The Australian Medical Association Limited and state AMA entities comply with the Privacy Act 1988. Please refer to the AMA Privacy Policy to understand our commitment to you and information on how we store and protect your data.

×

Search

×

AMA questions safety of pharmacy vaccinations

15 Jan 2014

The AMA has written to the Queensland Government’s Chief Health Officer raising serious patient safety concerns about a Queensland trial of community pharmacists providing flu vaccinations.

AMA President, Dr Steve Hambleton, said today that the trial should be stopped immediately.

“Pharmacies have no proven record that they are safe or appropriate locations for such a private and potentially risky clinical procedure as vaccination,” Dr Hambleton said.

“Vaccination saves lives and improves quality of life for millions of Australians and should be performed by appropriately trained and accredited health professionals – doctors – or under direct supervision of doctors in a safe and private clinical environment.

“The AMA believes that general practice is the appropriate location for vaccination, with the procedure conducted by a highly-trained and accredited GP or by an appropriately trained and qualified general practice nurse under the supervision of a GP.

“Pharmacists provide the community with a highly valued service – as pharmacists. They should not pretend to be doctors.”

Dr Hambleton said that all medicines carry benefits and risks.

“Health practitioners who perform vaccinations must have specific training that includes how to make an assessment about the safety of the vaccine for a particular patient, and how to recognise and respond to adverse reactions,” Dr Hambleton said.

“It is not in the interests of patient safety for pharmacists to participate in this irresponsible trial. It could even be dangerous.

“There are issues with privacy, training, accreditation, qualifications, side effects, patients’ medical history, consistency of medical records, sterilisation of equipment, appropriate storage of vaccines, and professional indemnity, to name just a few.

“Is there a loading on the professional indemnity insurance for pharmacists who wish to participate in the trial?

“Where is the private area to seek consent?

“Where is the private bed to assist patients who wish to lie down?

“Where is the private area where patients can wait after vaccination until it is confirmed that there is no immediate allergic reaction?

“Where is the private area where a resuscitation can occur if needed, until the ambulance arrives?

“How do we prevent duplication of vaccination if there it is not an established routine to either seek information from the patient’s usual doctor or to inform the usual doctor?

“The safest way for people to receive vaccinations, whether for flu or to prevent other conditions, is through their usual general practice.

“Vaccinations outside general practice must be subject to the same proficiency and quality requirements as those provided within a general practice.

“The Queensland trial does not meet these requirements and must cease immediately,” Dr Hambleton said.


15 January 2014

CONTACT:        John Flannery                     02 6270 5477 / 0419 494 761
                       Kirsty Waterford                02 6270 5464 / 0427 209 753

Follow the AMA Media on Twitter: http://twitter.com/ama_media
Follow the AMA President on Twitter: http://twitter.com/amapresident
Follow Australian Medicine on Twitter:  https://twitter.com/amaausmed
Like the AMA on Facebook https://www.facebook.com/AustralianMedicalAssociation


Published: 15 Jan 2014